GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Smith & Nephew Snats, Inc. (SNN) [hlAlert]

Rating:
Outperform
SNN
up 56.33 %

Smith & Nephew Snats, Inc. (SNN) rated Outperform with price target $65 by Leerink Swann

Posted on: Friday,  May 2, 2008  10:25 AM ET by Leerink Swann

Leerink Swann rated Outperform Smith & Nephew Snats, Inc. (NYSE: SNN) on 05/02/2008, when the stock price was $22.69.
Since then, Smith & Nephew Snats, Inc. has gained 56.34% as of 12/07/2015's recent price of $35.47.
If you would have followed this Leerink Swann 's recommendation on SNN, you would have gained 56.33% of your investment in 2775 days.

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/2/2008 10:25 AM Buy
None
22.69 26.00
as of 12/24/2008
1 Week down  -1.56 %
1 Month up  0.29 %
3 Months up  3.64 %
1 YTD down  -40.28 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy